Plasma matrix metalloproteinase-9 better predicts outcome than N-terminal protype-B natriuretic peptide in patients with systolic heart failure and a high prevalence of coronary artery disease

Abstract Metalloproteinases have been proposed as biochemical markers of left ventricular (LV) remodeling in systolic heart failure (HF). However, their role in the prognostic stratification of these patients remains controversial. In the present study, we aimed at investigating the value of plasma...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Biomedicine & pharmacotherapy 2010-05, Vol.64 (5), p.339-342
Hauptverfasser:	Dini, Frank Lloyd, Buralli, Simona, Bajraktari, Gani, Elezi, Shpend, Duranti, Emiliano, Metelli, Maria Rita, Carpi, Angelo, Taddei, Stefano
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Aged, 80 and over Biological and medical sciences Biomarkers - blood Cardiology. Vascular system Coronary Artery Disease - complications Coronary heart disease Disease-Free Survival Echocardiography Echocardiography, Doppler Female Follow-Up Studies Heart Heart failure Heart failure, cardiogenic pulmonary edema, cardiac enlargement Heart Failure, Systolic - blood Heart Failure, Systolic - etiology Heart Failure, Systolic - physiopathology Humans Internal Medicine Kaplan-Meier Estimate Male Matrix Metalloproteinase 3 - blood Matrix Metalloproteinase 9 - blood Medical Education Medical sciences Metalloproteinases Middle Aged Multivariate Analysis Natriuretic Peptide, Brain - blood Natriuretic peptides Peptide Fragments - blood Pharmacology. Drug treatments Prognosis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!